WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- At today's National Prescription Drug Abuse Prevention Policy Consensus Meeting, the not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) announced the results of its national contest to identify the "Top 5 Technologies To Reduce Prescription Drug Abuse."
In alphabetical order, the Top 5 honorees are …
Honorable mention goes to Abuse Tech's Abuse-Loc, a locking medication bottle to prevent the diversion of drugs from homes.
The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.
Michael Barnes, spokesman for CLAAD, stated, "These companies have demonstrated a sincere commitment to reducing prescription drug abuse. We hope the Top 5 Technologies recognition will expedite their success in meeting that goal."
San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.
"We are proud to recognize the Top 5 honorees joining Millennium in the critically important effort to advance patient care and help address the epidemic of prescription drug abuse," said Howard Appel, President of Millennium Laboratories.
About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is the sponsor of the National Prescription Drug Abuse Prevention Policy Consensus meeting. In its fifth year, the annual event brings together representatives of government, non-profit health and safety organizations, and industry to identify how best to reduce prescription drug abuse while optimizing patient care. Follow @claad_coalition.
About Millennium Laboratories
Millennium Laboratories is the leading research-based, clinical diagnostic company dedicated to improving the lives of people with chronic pain and/or addiction. The company provides healthcare professionals with medication monitoring, drug detection and pharmacogenetic testing services to personalize treatment plans to improve clinical outcomes and patient safety.
Copyright©2012 PR Newswire.
All rights reserved